PEG-MGF – 2mg Peptide

PEG-MGF (2mg) — Research Compound

PEG-MGF (Pegylated Mechano Growth Factor) is a splice variant of Insulin-like Growth Factor-1 (IGF-1) that has been pegylated to increase its systemic half-life. It plays a critical role in local muscle repair and growth in response to mechanical stress or injury. By activating muscle-specific stem cells (satellite cells), PEG-MGF is studied for its ability to promote the fusion of new nuclei into existing muscle fibres, facilitating hypertrophy and tissue recovery.

Findings from early-stage clinical trials have reported:

• Significant increases in the activation and proliferation of satellite cells observed in experimental models
  
• Enhanced rates of muscle tissue regeneration following mechanical trauma reported in-vivo
  
• Improved protein synthesis markers and muscle fibre diameter increases noted in research studies
  
• Extended duration of biological activity observed compared to non-pegylated MGF variants
  

Researchers utilise PEG-MGF to explore the mechanisms of local tissue repair and the regulation of skeletal muscle mass. Its extended half-life allows for the study of sustained growth signalling without the requirement for frequent administration. This makes it a significant compound for research into sarcopenia, muscle wasting diseases, and the biological response to intensive mechanical load.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use